Immuneering Corp (IMRX) AI Dilution Summary

Estimated cash was $145,405,450 as of 2026-09-30, the same as the balance-sheet figure at that date, against estimated monthly burn of $5,595,085. The active at-the-market program with Piper Sandler & Co. is authorised to $98,749,993, with $0 sold to date. Dilution here is driven primarily by the S-3 shelf registration 333-289589.